For individuals who purchased or paid for some or all of the purchase price for Aggrenox and/or its generic versions in certain parts of America between the dates of November 30, 2009 through December 22, 2017, you may be eligible for a potential reward from the Aggrenox Generic Drug Delay Class Action Lawsuit! According to the lawsuit, indirect purchasers of Aggrenox unfairly paid a higher price for the drug when one drug maker, Barr, acquired Teva, which stalled the introduction of a generic equivalent onto the market. Boehringer Ingelheim Pharmaceuticals, Teva Pharmaceuticals USA, Barr Pharmaceuticals, Duramed Pharmaceuticals, and various marketing and other subsidiaries deny all acts of allegations, however, it has agreed to settle the class-action lawsuit in order to avoid the further risk and cost of ongoing litigation. Thus, if you are eligible, file a claim by September 14, 2018 to receive your potential award!
Aggrenox Generic Drug Delay CAL:
- Aggrenox Generic Drug Delay Claim Form
- Claim Form Deadline: 09/14/2018
- Who’s Eligible: There are two classes:
- Consumer who “Purchased and/or paid for Aggrenox or generic versions of Aggrenox, in the Commonwealth of Puerto Rico, Arizona, California, Colorado, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon (2010 or after), Rhode Island (purchases after July 15, 2013), South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin for consumption by yourself or your family, from November 30, 2009 through December 22, 2017.”
- Third-Parties who “Purchased, paid and/or reimbursed for Aggrenox or generic versions of Aggrenox, in the Commonwealth of Puerto Rico, Arizona, California, Colorado, District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon (2010 or after), Rhode Island (purchases after July 15, 2013), South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin for consumption by your consumers, employees, insured, participants or beneficiaries, between November 30, 2009 and December 22, 2017.”
- Estimated Amount: Varies. Payments will be based on various factors, such as the number of valid claims filed by all members of the settlement Class and the dollar value of each member of the Class’ purchase(s) in proportion to the total claims filed.
- Proof of Purchase: No
- Case Name & Number: In re: Aggrenox® Antitrust Litigation, Case No. 3:14-md-02516-SRU, in the U.S. District Court for the District of Connecticut
How To File a Claim:
- Head over to the Aggrenox Generic Drug Delay Claim Form.
- Look over the claim form to see if you are eligible.
- Complete the claim form with your information.
- Submit your claim by September 14, 2018 to receive your potential award!
Bottom Line:
If you’re an individual who purchased or paid for some or all of the purchase price for Aggrenox and/or its generic versions in certain parts of America between the dates of November 30, 2009 through December 22, 2017, you’re eligible for a potential award from the Aggrenox Generic Drug Delay Class Action Lawsuit! According to the lawsuit, consumers who purchased Aggrenox unfairly paid a higher price for the drug when Barr acquired Teva which stalled the introduction of a generic equivalent onto the market. If you’re eligible, be sure to file a claim by September 14, 2018 to receive your potential award! Don’t forget to take a look at our full list of Class Action Lawsuit Settlements!